• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Cardiovascular effects of glucagon-like peptide-1 receptor agonist therapies in patients with type 1 diabetes.

作者信息

Rizzo Manfredi, Rizvi Ali A, Sesti Giorgio

机构信息

Biomedical Department of Internal Medicine and Medical Specialties, University of Palermo, Palermo, Italy.

Division of Endocrinology, Diabetes and Metabolism, University of South Carolina School of Medicine, Columbia, South Carolina.

出版信息

Diabetes Obes Metab. 2017 May;19(5):613-614. doi: 10.1111/dom.12883. Epub 2017 Mar 2.

DOI:10.1111/dom.12883
PMID:28098425
Abstract
摘要

相似文献

1
Cardiovascular effects of glucagon-like peptide-1 receptor agonist therapies in patients with type 1 diabetes.胰高血糖素样肽-1受体激动剂疗法对1型糖尿病患者的心血管影响。
Diabetes Obes Metab. 2017 May;19(5):613-614. doi: 10.1111/dom.12883. Epub 2017 Mar 2.
2
No pancreatic safety concern following glucagon-like peptide-1 receptor agonist therapies: A pooled analysis of cardiovascular outcome trials.GLP-1 受体激动剂治疗后无胰腺安全性担忧：心血管结局试验的汇总分析。
Diabetes Metab Res Rev. 2018 Nov;34(8):e3061. doi: 10.1002/dmrr.3061. Epub 2018 Sep 14.
3
The Effect of Glucagon-Like Peptide 1 Receptor Agonists on Weight Loss in Type 2 Diabetes: A Systematic Review and Mixed Treatment Comparison Meta-Analysis.胰高血糖素样肽-1受体激动剂对2型糖尿病患者体重减轻的影响：一项系统评价与混合治疗比较的Meta分析
PLoS One. 2015 Jun 29;10(6):e0126769. doi: 10.1371/journal.pone.0126769. eCollection 2015.
4
Cardiovascular Actions and Clinical Outcomes With Glucagon-Like Peptide-1 Receptor Agonists and Dipeptidyl Peptidase-4 Inhibitors.胰高血糖素样肽-1 受体激动剂和二肽基肽酶-4 抑制剂的心血管作用和临床结局。
Circulation. 2017 Aug 29;136(9):849-870. doi: 10.1161/CIRCULATIONAHA.117.028136.
5
Glucagon-like Peptide-1 Receptor Agonists and Cardiovascular Events: Class Effects versus Individual Patterns.胰高血糖素样肽-1 受体激动剂与心血管事件：类别效应与个体模式。
Trends Endocrinol Metab. 2018 Apr;29(4):238-248. doi: 10.1016/j.tem.2018.01.011. Epub 2018 Feb 17.
6
Sgemaglutide in type 2 diabetes - is it the best glucagon-like peptide 1 receptor agonist (GLP-1R agonist)?司美格鲁肽用于2型糖尿病——它是最佳的胰高血糖素样肽1受体激动剂（GLP-1R激动剂）吗？
Expert Opin Drug Metab Toxicol. 2018 Mar;14(3):371-377. doi: 10.1080/17425255.2018.1441286. Epub 2018 Feb 23.
7
Effect of Glucagon-like Peptide-1 Receptor Agonists on All-cause Mortality and Cardiovascular Outcomes: A Meta-analysis.胰高血糖素样肽-1受体激动剂对全因死亡率和心血管结局的影响：一项荟萃分析。
Curr Diabetes Rev. 2018;14(3):273-279. doi: 10.2174/1573399813666170414101450.
8
Glucagon like peptide-1 and its receptor agonists: Their roles in management of Type 2 diabetes mellitus.胰高血糖素样肽-1及其受体激动剂：它们在2型糖尿病管理中的作用。
Diabetes Metab Syndr. 2017 Jul-Sep;11(3):225-230. doi: 10.1016/j.dsx.2016.09.003. Epub 2016 Sep 15.
9
Glucagon-Like Peptide-1 Receptor Agonists and Diabetic Cardiovascular Disease: Implications of the LEADER Study.胰高血糖素样肽-1受体激动剂与糖尿病心血管疾病：LEADER研究的启示
Metab Syndr Relat Disord. 2016 Oct;14(8):375-377. doi: 10.1089/met.2016.29008.swi. Epub 2016 Aug 23.
10
Do glucagon-like peptide-1 receptor (GLP-1R) agonists have potential as adjuncts in the treatment of type 1 diabetes?胰高血糖素样肽-1 受体 (GLP-1R) 激动剂是否有潜力作为 1 型糖尿病的辅助治疗药物？
Expert Opin Pharmacother. 2018 Oct;19(15):1655-1661. doi: 10.1080/14656566.2018.1519547. Epub 2018 Sep 20.

引用本文的文献

1
Advances in the Pharmacological Management of Diabetic Nephropathy: A 2022 International Update.糖尿病肾病的药理治疗进展：2022年国际最新情况
Biomedicines. 2023 Jan 20;11(2):291. doi: 10.3390/biomedicines11020291.
2
Liraglutide Reduces Carotid Intima-Media Thickness by Reducing Small Dense Low-Density Lipoproteins in a Real-World Setting of Patients with Type 2 Diabetes: A Novel Anti-Atherogenic Effect.在2型糖尿病患者的真实世界中，利拉鲁肽通过降低小而密低密度脂蛋白来减少颈动脉内膜中层厚度：一种新的抗动脉粥样硬化作用。
Diabetes Ther. 2021 Jan;12(1):261-274. doi: 10.1007/s13300-020-00962-3. Epub 2020 Nov 18.
3
Pharmacological Treatment in Diabetes Mellitus Type 1 - Insulin and What Else?
1型糖尿病的药物治疗——胰岛素及其他？
Int J Endocrinol Metab. 2017 Nov 20;16(1):e13008. doi: 10.5812/ijem.13008. eCollection 2018 Jan.